Open-label use of highly purified CBD (Epidiolex?) in patients with CDKL5 deficiency disorder and Aicardi, Dup15q, and Doose syndromes
- 浏览3
Epilepsy & behavior
131-137页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文

131-137页
